Optimization of the postembolization period in patients with uterine myoma

DOI: https://dx.doi.org/10.18565/aig.2017.12.110-114

Yudina T.A., Manukhin I.B., Tikhomirov A.L.

1 SM-Clinic, Moscow, Klary Tsetkinoi str. 33/28, Russia; 2 A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow 127473, Delegatskaya str. 20, bld. 1, Russia
Objective. To investigate the efficacy of a venous protector in the complex relief of postembolization syndrome in patients with uterine myoma after uterine artery embolization (UAE).
Subjects and methods. 30 patients with uterine myoma and signs of venous/lymphatic insufficiency in the legs (Group 1) were given a venous protector (hesperidin 50 mg, diosmin 450 mg) as one tablet (500 mg) twice daily for one month on the first day following UAE. A control group (Group 2) consisted of 30 patients with post-UAE uterine myoma and without signs of venous/lymphatic insufficiency in the legs, who were not treated with a venous protector. The patients of the analyzed groups were matched for age, the location, size, and number of myomatous nodes. The time course of changes in the regression of myomatous nodes was assessed from ultrasonographic findings at 3 months after UAE. The degree of post-UAE pain syndrome was estimated using a 10-point scale.
Results. All the patients described the nature of pain syndrome in the first week after UAE equally; however, the 10-point scale intensity was much more pronounced in Group 2. Regression of myomatous nodes was more pronounced in Group 1 patients (36.5% versus 20.3%).
Conclusion. The findings may suggest that venous protective therapy can be used in patients undergoing UAE as a technique to optimize X-ray endovascular treatment and to reduce the severity of postembolization syndrome especially in patients with uterine myoma and venous/lymphatic insufficiency in the lower limbs.

Supplementary Materials


References


1. Григорян P.A., Богачев В.Ю., Золотухин И.А. Варикозная болезнь. В кн.: Савельев В.С., ред. Флебология. М.: Медицина; 2001: 438-90. [Grigoryan P.A., Bogachev V.Yu., Zolotukhin I.A. Varicose disease. In the book: Savelyev VS, ed. Phlebology. Moscow: Medicine; 2001: 438-90. (in Russian)]

2. Гаврилов С.Г., Кириенко А.И., Доброхотова Ю.Э., Каралкин А.В., Москаленко Е.П., Гришин И.И., Балашов А.В., Авалишвили О.О. Дифференциальная диагностика хронических тазовых болей у женщин в свете синдрома тазового венозного полнокровия. Российский вестник акушера-гинеколога. 2006; 6(4): 49-53. [Gavrilov S.G., Kirienko A.I., Dobrohotova Yu.E., Karalkin A.V., Moskalenko E.P., Grishin I.I., Balashov A.V., Avalishvili O.O. Differential diagnosis of chronic pelvic pain in women in the light of pelvic venous congestion syndrome. Rossiyskiy vestnik akushera-ginekologa. 2006; 6(4): 49-53. (in Russian)]

3. Кириенко А.И., Богачев В.Ю., Прокубовский В.И. Варикозная болезнь вен малого таза. В кн.: Савельев В.С., ред. Флебология. М.: Медицина; 2001: 574-80. [Kirienko A.I., Bogachev V.Yu., Prokubovskiy V.I. Varicose veins of the pelvic floor. In the book: Savelyev VS, ed. Phlebology. Moscow: Medicine; 2001: 574-80. (in Russian)]

4. Kim H.P., Son K.H., Chang H.W., Kang S.S. Anti-inflammatory plant flavonoids and cellular action mechanisms. J. Pharmacol. Sci. 2004; 96(3): 229-45.

5. Gabor M. Abriss der Pharmakologie von Flavonoiden. Budapest: Akademiai Kiado; 1975.

6. Barreca D., Laganà G., Bruno G., Magazù S., Bellocco E. Diosmin binding to human serum albumin and its preventive action against degradation due to oxidative injuries. Biochimie. 2013; 95(11): 2042-9.

7. Lu H., Shi J.X., Zhang D.M., Chen H.L., Qi M., Yin H.X. Enistein, a soybean isoflavone, reduces the production of pro-inflammatory and adhesion molecules induced by hemolysate in brain microvascular endothelial cells. Acta Neurol. Belg. 2009; 109(1): 32-7.

8. Тихомиров А.Л., Лубнин Д.М. Эмболизация маточных артерий в лечении миомы матки. Вопросы гинекологии, акушерства и перинатологии. 2002; 1(2): 83-5. [Tikhomirov A.L., Lubnin D.M. Embolization of uterine arteries in the treatment of uterine myomas. Voprosyi ginekologii, akusherstva i perinatologii. 2002; 1(2): 83-5. (in Russian)]

9. Тихомиров А.Л., Лубнин Б.М. Миома матки. М.; 2006. 176с. [Tihomirov A.L., Lubnin B.M. Myoma of the uterus. Moscow; 2006. 176p. (in Russian)]

10. Тихомиров А.Л. Патогенетическое обоснование ранней диагностики, лечения и профилактики миомы матки: дисс. … д-ра мед. наук. М.; 1998. [Tikhomirov A.L. Pathogenetic justification for early diagnosis, treatment and prevention of uterine fibroids: diss. ... Dr. med. sciences. Moscow; 1998. (in Russian)]

Received 08.09.2017

Accepted 22.09.2017


About the Autors


Yudina Tatiana Alexandrovna, gynecologist of the multi-profile medical holding SM-Clinic. Russia, Moscow, Klary Tsetkinoi str. 33/28. Tel.: +74957774849
Manukhin Igor Borisovich, MD, professor, head of the Department of Obstetrics and Gynecology, Medical Faculty, A.I. Evdokimov Moscow State University of Medicine and Dentistry. 127473, Russia, Moscow, Delegatskaya str. 20, bld. 1. Tel.: +74991782831
Tikhomirov Alexander Leonidovich, MD, Professor of the Department of Obstetrics and Gynecology, Medical Faculty, A.I. Evdokimov Moscow State University of Medicine and Dentistry. 127473, Russia, Moscow, Delegatskaya str. 20, bld. 1. Tel.: +74991782831. E-mail: pacificoff@mail.ru

For citations: Yudina T.A., Manukhin I.B., Tikhomirov A.L. Optimization of the postembolization period in patients with uterine myoma. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2017; (12): 110-4. (in Russian)
https://dx.doi.org/10.18565/aig.2017.12.110-114


Similar Articles

Бионика Медиа